Skip to content
← Full study record

NCT02749617 · FLOW

Participant flow

A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma · Source last updated 2021-08-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    apixaban 2.5 mg PO BID apixaban: 2.5 mg PO BID
    id
    FG000
    title
    Apixaban
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        2
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        2
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    apixaban 2.5 mg PO BID apixaban: 2.5 mg PO BID
    id
    FG000
    title
    Apixaban
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        2
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        2
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice